-

BioConnect Acquires Silent Partner Technologies to Expand Offerings for Intelligent Asset Tracking and Inventory Management to Bring Security and Accountability to Critical Assets Ranging From Controlled Narcotics to First Responder Gear

Following BioConnect’s acquisition of MedixSafe in 2021, the expanded capabilities within BioConnect’s Trust Platform will provide the ability to monitor the full “Chain of Custody” for controlled substances to help end the drug diversion contributing to the Opioid Crisis.

  • BioConnect has the largest installation base of biometric physical access devices in North America with over 18K active subscriptions, serving much of the Fortune 100 and over 80% of the top data centers.
  • MedixSafe by BioConnect sets the bar for quality American made cloud connected narcotic safes with best-in-class construction and FBI certified biometric access control for EMS/Fire Vehicles, Stations, and Clinics.
  • Silent Partner Technologies has been a leader in RFID asset and inventory management for the last 20 years with exceptional custom installation services and over 1500 customers spanning EMS & Fire to Fleet Management and Heavy Machinery Compliance.

TORONTO & MEMPHIS, Tenn. & TAMPA, Fla.--(BUSINESS WIRE)--BioConnect has acquired Silent Partner Technologies, Inc. (SPT), headquartered in Tampa Florida – a leading provider of RFID Inventory and Asset management software, expanding BioConnect’s leading Trusted Security Platform to create the most advanced cloud based smart safes, smart lockers, smart cabinets, smart rooms and smart vehicles for the intelligent “chain of custody” and security assurance for any critical asset.

Portfolios of both companies complement each other perfectly.

“Bringing security and accountability to assets ranging from Narcotics and Controlled Goods to First Responder Gear and IT assets is becoming increasingly critical in today’s environment and in particular eliminating Drug Diversion feeding the Opioid crisis. With the acquisition of Silent Partner Technologies, together we will offer a simple cloud subscription to upgrade any area protecting assets to become the next generation ‘Smart Space’ solution. Customers looking for higher security and ‘chain of custody’ accountability to protect their critical assets will find this solution very compelling,” commented Rob Douglas, Founder and CEO of BioConnect. “BioConnect plus Silent Partner Technologies place the combined company in the leadership quadrant for Securing Things.”

The Fire and EMS market for BioConnect has grown at 100% year over year since the purchase of MedixSafe in 2021 and the company remains committed to an “American Made” footprint and will operate this new line of business under Ryan Mueller the 13-year veteran of BioConnect and newly appointed General Manager.

“MedixSafe and SPT both have a significant installation base with EMS & Fire agencies and those customers will benefit from the unification under BioConnect’s Trust platform,” Rob Douglas continued, “I’m also excited to congratulate Ryan Mueller on his promotion to General Manager to lead this business unit, Ryan has a wealth of experience at BioConnect over the last 13 years leading customer experience, professional services and delivery and is ideal to spearhead the integration and expansion of this new business for us.”

About BioConnect:

Built by IT professionals for IT professionals, BioConnect provides an enterprise biometric and multi-factor authentication & security platform to establish stronger identity trust for the protection of the most valuable enterprise assets, their people, data and assets. For four consecutive years, BioConnect’s Trust Platform has received innovation awards from the Security Industry Association (SIA) and the 2023 EMS Innovation Award; along with being named a top quadrant leader in Access Control by Frost & Sullivan in 2022. Founded in Toronto, Canada in 2010, fast forward to today with over 18,000 active subscription customers predominantly in the USA and over 60 integration and strategic partnerships with leading security industry providers such as AMAG, Assa Abloy, Brivo, Cisco, Convergint, Genetec, HID, Johnson Controls, Lenel, and Software House.

In 2021, MedixSafe was purchased by BioConnect, a long time MedixSafe partner and supplier of biometric (fingerprint) solutions for secure access to MedixSafe devices. Together BioConnect and MedixSafe are uniquely positioned to offer solutions to the toughest security problems that an organization faces, providing security at scale that establishes a strong level of trust by unifying a person’s identity across physical, IoT and digital applications.

Contacts

Julia Webb-Twoomey
VP, Corporate Development & Marketing
Phone: 818-398-9061
jwebb@bioconnect.com

BioConnect


Release Versions

Contacts

Julia Webb-Twoomey
VP, Corporate Development & Marketing
Phone: 818-398-9061
jwebb@bioconnect.com

More News From BioConnect

BioConnect Launches the Arc Series: Biometric Devices for Zero Trust Authentication

NEW YORK--(BUSINESS WIRE)--BioConnect, the market leader in AI-powered biometric and multi-modal authentication, today introduced its highly anticipated Arc Series biometric devices. Designed to address the evolving security, compliance, and scalability needs of enterprises and data centers, the Arc Series sets a new standard in modern access control. The launch includes three innovative devices: Arc Vision, a facial authentication device; Arc Touch, a fingerprint authentication device; and the...

BioConnect Introduces its Trusted Identity Service to Revolutionize Physical Access Security

TORONTO--(BUSINESS WIRE)--BioConnect, a leader in biometric authentication solutions, unveils its groundbreaking "Trusted Identity Service" featuring AI Based Face Authentication for securing physical access points. This cutting-edge solution, anchored by an outdoor-rated Face Authentication Reader, sets new standards in overall value with the combination of performance, integration, and security. "With our monthly subscription based Trusted Identity Service, we are not just providing security;...

BioConnect’s MedixSafe Solution Wins the 2023 EMS Innovation Award for Its Narcotic Safe Retrofit Kit

MEMPHIS, Tenn. & TORONTO--(BUSINESS WIRE)--State & Federal Compliance requirements are an ongoing challenge for EMS Agencies today, especially the evolving requirements related to narcotic storage and record keeping. BioConnect has designed the MedixSafe Retrofit Fit solution to help with the financial and operational challenge of aging infrastructure in the face of increasing stringent compliance requirements to continue as a licensed provider of controlled substances. The MedixSafe Retrof...
Back to Newsroom